Revenue - Cuu Long Pharmaceutical JSC (VN:DCL) - Alpha Spread
C

Cuu Long Pharmaceutical JSC
VN:DCL

Watchlist Manager
Cuu Long Pharmaceutical JSC
VN:DCL
Watchlist
Price: 25 650 VND -0.39%
Market Cap: 1.9T VND
Have any thoughts about
Cuu Long Pharmaceutical JSC?
Write Note

Cuu Long Pharmaceutical JSC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cuu Long Pharmaceutical JSC
Revenue Peer Comparison

Comparables:
H
DHT
I
IMP
D
DMC
D
DHG
T
TRA

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
Cuu Long Pharmaceutical JSC
VN:DCL
Revenue
â‚«1.1T
CAGR 3-Years
19%
CAGR 5-Years
7%
CAGR 10-Years
N/A
H
HaTay Pharmaceutical JSC
VN:DHT
Revenue
â‚«2T
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
9%
I
Imexpharm Corp
VN:IMP
Revenue
â‚«2.1T
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
10%
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Revenue
â‚«1.8T
CAGR 3-Years
8%
CAGR 5-Years
-8%
CAGR 10-Years
1%
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Revenue
â‚«5T
CAGR 3-Years
7%
CAGR 5-Years
-5%
CAGR 10-Years
3%
T
Traphaco JSC
VN:TRA
Revenue
â‚«2.3T
CAGR 3-Years
-15%
CAGR 5-Years
-5%
CAGR 10-Years
4%

See Also

What is Cuu Long Pharmaceutical JSC's Revenue?
Revenue
1.1T VND

Based on the financial report for Dec 31, 2023, Cuu Long Pharmaceutical JSC's Revenue amounts to 1.1T VND.

What is Cuu Long Pharmaceutical JSC's Revenue growth rate?
Revenue CAGR 5Y
7%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Cuu Long Pharmaceutical JSC have been 19% over the past three years , 7% over the past five years .

Back to Top